You can never be too sure these days with FDA. Biden will not be President by that time. Investors are seeing risks in company with poor records for growth and margins.
GLTA
- Forums
- ASX - By Stock
- Ann: Bubs Q4 FY24 Quarterly Activity and Cashflow Statement
You can never be too sure these days with FDA. Biden will not be...
Featured News
Add BUB (ASX) to my watchlist
(20min delay)
|
|||||
Last
11.8¢ |
Change
0.003(2.17%) |
Mkt cap ! $102.7M |
Open | High | Low | Value | Volume |
12.0¢ | 12.0¢ | 11.5¢ | $3.694K | 31.12K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
77 | 5352408 | 11.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.0¢ | 1277323 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
77 | 5352408 | 0.115 |
70 | 2943696 | 0.110 |
19 | 960207 | 0.105 |
39 | 1006122 | 0.100 |
2 | 100870 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.120 | 1277323 | 16 |
0.125 | 1293056 | 20 |
0.130 | 1929645 | 39 |
0.135 | 1288710 | 27 |
0.140 | 2075195 | 25 |
Last trade - 10.28am 12/11/2024 (20 minute delay) ? |
Featured News
BUB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online